A Study to Evaluate Continuous Glucose Monitor in Hospitalized, Post-operative Patients With Diab… (NCT04845685) | Clinical Trial Compass
SuspendedNot Applicable
A Study to Evaluate Continuous Glucose Monitor in Hospitalized, Post-operative Patients With Diabetes Mellitus
Stopped: Unable to secure funding
United States50 participantsStarted 2026-06
Plain-language summary
The purposes of this study is to study if CGMs worn in the postoperative ICU or non-ICU hospital setting have adequate accuracy for blood glucose monitoring when compared to point-of-care (POC) capillary glucometers.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with Type 1 or 2 Diabetes Mellitus.
* Patients 18 years of age or older.
* Admitted for deceased donor renal transplant surgery, pancreas transplant surgery, heart transplant surgery, liver transplant surgery and lung transplant surgery.
* Anticipated minimum of 72h hospital stay.
* Patients on insulin therapy (IV, SQ) post-surgery.
Exclusion Criteria:
* Active COVID-19 infection.
* Pregnant or lactating female.
* Altered Mental Status at the time of sensor placement (sensor will be placed once mental status will improve).
* Inability to provide informed consent.
* Patients taking more than 4 g of acetaminophen in 24 hours or more than 1 gm every 6 hours.
Patients with skin lesions at the application site that may interfere with placement of the sensor.
Patients with known allergy to medical grade adhesive.
What they're measuring
1
CGM accuracy
Timeframe: From date of enrollment and until discharge from the hospital up to 30 days.